Elizabeth Arden, Inc. is proud to announce the launch of Britney Spears™ believe official website featuring the new fragrance by Britney Spears, which is now available for pre-order online from the Elizabeth Arden Online Fragrance Store.
Be the first to own BRITNEY SPEARS™ believe and receive an exclusive BRITNEY SPEARS™ believe T-shirt as your FREE gift while supplies last. Pre-order now. Ships 9/24/2007
Ceramide Ultra Gold Capsules are now available for purchase online from the Elizabeth Arden Online Store.
Also available for consumers who wish to learn more about skincare and how Ceramide can help slow aging signs in skin, Tony Vargas, Elizabeth Arden’s Vice President of research and Development, offers his expert advice on Ceramide.
Elizabeth Arden, Inc. is proud to announce the launch of Mediterranean, The Fragrance Website which features the inspiration behind the fragrance, the design and the overall Mediterranean Collection. Fans are treated with extra goodies such as screen savers and wall papers.
NEW YORK, May 03, 2007 — Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products company, today announced financial results for the fiscal 2007 third quarter ended March 31, 2007.
THIRD QUARTER RESULTS
Net sales increased 14.6% to $219.2 million for the three months ended March 31, 2007 from $191.3 million in the comparable period of the prior year. Net sales growth was driven by increased sales of prestige fragrances to mass retail customers, sales of new fragrances, including Elizabeth Arden Mediterranean and with Love… Hilary Duff, and higher sales globally of the Elizabeth Arden brand. Excluding the favorable impact of foreign currency translation, net sales increased 12.6%.
Net income for the three months ended March 31, 2007 was $3.2 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.02 per diluted share, in the same period last year. Earnings for the current year period were positively impacted by a tax benefit of $0.01 per diluted share related to R&D tax credits. Earnings for the prior year period include debt extinguishment charges of $0.02 per diluted share.
E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc., commented, “The key drivers of our business performed well this quarter, and we expect this trend to continue for the remainder of this fiscal year and into fiscal 2008. Our U.S. mass retail business delivered another strong quarter. Net sales of the mass business unit grew by 26%, well ahead of the category growth, and we are expanding our market share with those retailers. The second key driver, our international business, increased over 10% led by strong growth in the Asia Pacific and travel retail markets. Global sales of Elizabeth Arden branded skin care and color products are growing rapidly and have experienced double-digit increases so far this fiscal year. We expect growth of the Elizabeth Arden brand in total to continue to accelerate due to the recent launch of our new fragrance Elizabeth Arden Mediterranean.”
Mr. Beattie continued, “During the third quarter we also integrated the remaining functions related to the acquisition of Sovereign Sales. With the transition costs essentially behind us, we expect the acquisitions, along with a strong pipeline of new fragrance brands for the U.S. mass retail market, to contribute to improved operating earnings and earnings growth for the balance of this fiscal year and fiscal 2008.”
NINE MONTHS RESULTS
For the nine months ended March 31, 2007, net sales rose 15.7% to $884.8 million from $764.6 million for the nine months ended March 31, 2006. Excluding the favorable impact of foreign currency translation, net sales increased 14.5%. Net income was $27.7 million, or $0.97 per diluted share, versus $34.7 million, or $1.17 per diluted share, for the year-ago period. The results for the nine months ended March 31, 2007 include restructuring charges of $0.05 per diluted share related to the Company’s previously announced restructuring, and results for the prior nine-month period include debt extinguishment charges of $0.02 per diluted share.
OUTLOOK
The Company confirms its fiscal 2007 net sales and earnings guidance and expects diluted earnings per share in the range of $1.15 to $1.20 and net sales to increase by 15% to 18% over prior fiscal year net sales of $954.6 million. The Company notes that it utilizes foreign currency hedges and that its net sales guidance is based on current foreign currency rates. The earnings guidance reflects no change to the full fiscal year anticipated effective tax rate of 25.6%. The earnings guidance also excludes restructuring charges.
CONFERENCE CALL INFORMATION
The Company will host a conference call today at 4:30 p.m. Eastern Time. All interested parties can listen to a live web cast of the Company’s conference call by logging on to the Company’s web site at Company’s Calendar of Events. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Elizabeth Arden Corporate Website until June 3, 2007.
Elizabeth Arden is a global prestige beauty products company. The Company’s portfolio of brands includes the Elizabeth Arden fragrance brands: Red Door, Elizabeth Arden 5th Avenue, Elizabeth Arden green tea and Elizabeth Arden Mediterranean; the Elizabeth Taylor fragrance brands: White Diamonds and Elizabeth Taylor’s Passion; the fragrance brands of Britney Spears: curious Britney Spears and fantasy Britney Spears; the Hilary Duff fragrance with Love… Hilary Duff; the Danielle Steel fragrance Danielle by Danielle Steel; the classic fragrances: Design, Giorgio Beverly Hills, Halston and Halston Z-14, White Shoulders and Wings; the men’s fragrances: Daytona 500, GANT, Geoffrey Beene’s Grey Flannel, the HUMMER™ Fragrance for Men and PS Fine Cologne for Men; and the designer fragrance brands of Alfred Sung, Badgley Mischka and Bob Mackie; the Elizabeth Arden skin care lines, Ceramide, Intervene and PREVAGE™ anti-aging treatment and the Elizabeth Arden color cosmetics line.
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance regarding net sales, earnings and cash flow from operations. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations:
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF OPERATIONS DATA (Unaudited) (In thousands, except percentages and per share data) Three Months Ended Nine Months Ended ———————- ———————- March 31, March 31, March 31, March 31, 2007 2006 2007 2006 ——— ——— ——— ——— Net Sales $ 219,223 $ 191,344 $ 884,802 $ 764,615 Cost of Sales 120,744 105,094 529,143 443,539 ——— ——— ——— ——— Gross Profit 98,479 86,250 355,659 321,076 Gross Profit Percentage 44.9 % 45.1 % 40.2 % 42.0 % Selling, General and Administrative Expenses 82,090 75,929 277,696 238,424 Depreciation and Amortization 6,042 5,438 18,740 16,087 ——— ——— ——— ——— Total Operating Expenses 88,132 81,367 296,436 254,511 Interest Expense, Net 6,552 5,344 22,441 18,120 Debt Extinguishment Charge – 758 – 758 Income Before Income Taxes 3,795 (1,219) 36,782 47,687 Provision for (Benefit From) Income Taxes 638 (1,921) 9,083 12,995 ——— ——— ——— ——— Net Income $ 3,157 $ 702 $ 27,699 $ 34,692 ========= ========= ========= ========= As reported: ———————- Basic Income Per Share $ 0.11 $ 0.02 $ 1.00 $ 1.22 Diluted Income Per Share $ 0.11 $ 0.02 $ 0.97 $ 1.17 Basic Shares 27,455 28,412 27,566 28,487 Diluted Shares 28,754 29,636 28,581 29,633 EBITDA (a) $ 16,389 $ 9,563 $ 77,963 $ 81,894 Adjusted to exclude the effect of debt extinguishment and restructuring charges, net of taxes (b): Net Income $ 3,271 $ 1,254 $ 29,058 $ 35,244 Basic Income Per Share $ 0.12 $ 0.04 $ 1.05 $ 1.24 Diluted Income Per Share $ 0.11 $ 0.04 $ 1.02 $ 1.19 Basic Shares 27,455 28,412 27,566 28,487 Diluted Shares 28,754 29,636 28,581 29,633 EBITDA (a) $ 16,526 $ 10,321 $ 79,768 $ 82,652 (a) EBITDA is defined as net income plus the provision for income taxes, plus interest expense, plus depreciation and amortization. EBITDA should not be considered as an alternative to operating income or net income (as determined in accordance with generally accepted accounting principles (GAAP)) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with GAAP) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company’s operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure, depreciation and amortization or non-operating factors (such as historical cost). Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures. The following is a reconciliation of net income, as determined in accordance with GAAP, to EBITDA: (For a reconciliation of net income to EBITDA for prior periods, see the Company’s filings with the Securities and Exchange Commission which can be found on the Company’s website at www.elizabetharden.com). Three Months Ended Nine Months Ended ——————– ——————- (In thousands) March 31, March 31, March 31, March 31, 2007 2006 2007 2006 ———- ——— ——— ——— Net income $3,157 $702 $27,699 $34,692 Plus: Provision for (benefit from) income taxes 638 (1,921) 9,083 12,995 Interest expense, net 6,552 5,344 22,441 18,120 Depreciation and amortization 6,042 5,438 18,740 16,087 ———- ——— ——— ——— EBITDA 16,389 9,563 77,963 81,894 Debt extinguishment charge – 758 – 758 Restructuring charges 137 – 1,805 – ———- ——— ——— ——— EBITDA adjusted to exclude debt extinguishment and restructuring charges $16,526 $10,321 $79,768 $82,652 ========== ========= ========= ========= (b) The following table reconciles the calculation of net income per share on a basic and diluted basis from the amounts reported in accordance with GAAP to such amounts before giving effect to the impact of debt extinguishment and restructuring charges. This disclosure is being provided because we believe it is meaningful to our investors and other interested parties to understand the Company’s operating performance for comparability purposes and on a consistent basis without regard to the impact of debt extinguishment and restructuring charges. The presentation of the non-GAAP information titled ”Net income per share as adjusted, before the effect of debt extinguishment and restructuring charges, net of taxes” is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with GAAP. (In thousands, except per share data) Three Months Ended Nine Months Ended ——————- ——————- March 31, March 31, March 31, March 31, 2007 2006 2007 2006 ——— ——— ——— ——— As reported: —————————— Basic Net income as reported $ 3,157 $ 702 $27,699 $34,692 ======= ======= ======= ======= Weighted average shares outstanding as reported 27,455 28,412 27,566 28,487 ======= ======= ======= ======= Net income per basic share as reported $ 0.11 $ 0.02 $ 1.00 $ 1.22 ======= ======= ======= ======= Diluted Net income as reported $ 3,157 $ 702 $27,699 $34,692 ======= ======= ======= ======= Weighted average shares and potential dilutive shares as reported 28,754 29,636 28,581 29,633 ======= ======= ======= ======= Net income per diluted share as reported $ 0.11 $ 0.02 $ 0.97 $ 1.17 ======= ======= ======= ======= Adjusted to exclude the effect of debt extinguishment and restructuring charges, net of taxes —————————— Basic Net income as reported $ 3,157 $ 702 $27,699 $34,692 Debt extinguishment charge, net of tax – 552 – 552 Restructuring charges, net of tax 114 – 1,359 – ——- ——- ——- ——- Net income as adjusted, before the effect of debt extinguishment and restructuring charges, net of taxes $ 3,271 $ 1,254 $29,058 $35,244 ======= ======= ======= ======= Weighted average shares outstanding as reported 27,455 28,412 27,566 28,487 ======= ======= ======= ======= Net income per share as adjusted, before the effect of debt extinguishment and restructuring charges, net of taxes $ 0.12 $ 0.04 $ 1.05 $ 1.24 ======= ======= ======= ======= Diluted Net income as reported $ 3,157 $ 702 $27,699 $34,692 Debt extinguishment charge, net of tax – 552 – 552 Restructuring charges, net of tax 114 – 1,359 – ——- ——- ——- ——- Net income as adjusted, before the effect of debt extinguishment and restructuring charges, net of taxes $ 3,271 $ 1,254 $29,058 $35,244 ======= ======= ======= ======= Weighted average shares outstanding as reported 28,754 29,636 28,581 29,633 ======= ======= ======= ======= Net income per diluted share as adjusted, before the effect of debt extinguishment and restructuring charges, net of taxes $ 0.11 $ 0.04 $ 1.02 $ 1.19 ======= ======= ======= ======= CONSOLIDATED BALANCE SHEET DATA (Unaudited) (In thousands) March 31, June 30, March 31, 2007 2006 2006 ———- ———- ———- Cash $ 37,761 $ 28,466 $ 27,309 Accounts Receivable, Net 213,484 181,080 187,953 Inventories 327,184 269,270 239,628 Property and Equipment, Net 38,662 34,681 32,926 Exclusive Brand Licenses, Trademarks and Intangibles, Net 219,084 201,534 184,717 Total Assets 878,566 759,903 714,491 Short-Term Debt 114,840 40,000 30,296 Current Portion of Long-Term Debt 1,125 563 – Current Liabilities 323,278 234,978 183,317 Long-Term Liabilities 248,425 247,078 233,943 Total Debt 340,433 265,951 252,801 Shareholders’ Equity 306,863 277,848 297,230 Working Capital 290,732 280,942 305,491
CONTACT: Elizabeth Arden, Inc.
Marcey Becker, 203-462-5809
or
Investor/Press:
Integrated Corporate Relations
Allison Malkin / Michael Fox, 203-682-8200
SOURCE: Elizabeth Arden, Inc.
NEW YORK — Feb. 1, 2007–Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products company, today announced financial results for the fiscal 2007 second quarter ended December 31, 2006.
SECOND QUARTER RESULTS
Net sales increased 18.8% to $410.8 million for the three months ended December 31, 2006 from $345.9 million in the comparable period of the prior year. Sales growth was driven by a significant increase in fragrance brands sold to the Company’s mass retail customers, sales of new brands, including the With Love… Hilary Duff fragrance and the fragrance brands resulting from the June 2006 Riviera Concepts acquisition. In addition, higher sales of the Company’s Elizabeth Arden branded skin care and color products and growth in the Company’s businesses in China and Taiwan contributed to the net sales increase. Excluding the favorable impact of foreign currency translation, net sales increased 17.3%.
Net income for the three months ended December 31, 2006 was $26.2 million, or $0.92 per diluted share, excluding previously announced restructuring charges of $0.3 million after taxes related to the Company’s restructuring in its European operations, compared to net income of $33.1 million, or $1.12 per diluted share, in the same period last year. On a reported basis, net income was $25.9 million, or $0.91 per diluted share. As previously announced, the Company’s earnings for the second quarter of fiscal 2007 were impacted by transition and integration expenses associated with the Company’s recent acquisitions.
E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc., commented, “We are pleased with our second quarter results and the general execution of our business. Our better than planned earnings reflect the strength of our broad-based business model, which spans multiple retail channels and geographies, as well as the strength of our brand portfolio. Overall, the recent acquisitions are performing ahead of our original expectations. We have completed the transition of the distribution activities out of the Sovereign Sales facility and are on schedule to integrate all remaining functions during the third fiscal quarter. Although With Love… Hilary Duff ranked among the top three Fall fragrance launches at U.S. department stores, our recently launched fragrances were short of our internal retail sales expectations, largely due to a softer than expected holiday season for fragrances at U.S. department stores. The rest of our business units, however, performed at or better than plan.”
Mr. Beattie continued, “Our U.S. mass retail business increased significantly, and we are expanding our market share. This growth was led by the acquisitions and the strength of the Britney Spears fragrance franchise, which experienced double-digit gains this quarter in sales to mass retailers as well as in our international markets.”
Mr. Beattie added, “In addition, net sales of our Elizabeth Arden branded skin care and color products rose 18% this quarter and 20% for the first half of the fiscal year. This is a result of our very strong product innovation and improved brand promotion and advertising globally. Our international business achieved another quarter of solid sales growth, with increases across most markets and particularly in Asia. Our focus on the Elizabeth Arden brand, including the introduction of products such as PREVAGE™ anti-aging treatment, is also resulting in improved retail sales and productivity at U.S. department stores. The repositioning of PREVAGE™ to the beauty counter, for example, has lifted the retail performance of our Elizabeth Arden skin care and color business.”
SIX MONTHS RESULTS
For the six-months ended December 31, 2006, net sales rose 16.1% to $665.6 million from $573.3 million for the six months ended December 31, 2005. Excluding the favorable impact of foreign currency translation, net sales increased 15.0%. Net income was $25.8 million, or $0.91 per diluted share, versus $34.0 million, or $1.15 million per diluted share, for the year-ago period. The results for the six months ended December 31, 2006 exclude restructuring charges of $1.2 million after taxes related to the Company’s previously announced restructuring charges. On a reported basis, net income was $24.5 million, or $0.86 per diluted share.
OUTLOOK
The Company confirms its fiscal 2007 annual net sales guidance. For the fiscal year, the Company currently anticipates net sales will increase by approximately 15% to 18%, assuming current foreign currency rates. The Company is raising the lower end of its fiscal 2007 earnings guidance range and currently estimates diluted earnings per share in the range of $1.15 to $1.20, versus its previous guidance range of $1.10 to $1.20.
The Company currently expects net sales to range between $215 million to $230 million for each of the third and fourth fiscal quarters. Diluted earnings per share for the third fiscal quarter are currently estimated to be in the range of $0.01 to $0.06. The Company expects to incur in its third fiscal quarter the final transition expenses for the Sovereign Sales acquisition and increased investment to support the global roll-out of the With Love… Hilary Duff fragrance, PREVAGE™ Eye skin treatment and the Intervene skin care line and the global launch of the new Elizabeth Arden fragrance, Elizabeth Arden Mediterranean.
Mr. Beattie concluded, “As we look forward to the second half of the year, we are excited about the global introduction of the new Elizabeth Arden fragrance, Elizabeth Arden Mediterranean, to support the strong growth of the Elizabeth Arden skin care and color business globally. Prevage Eye continues to gain traction and is lifting total sales of the Prevage™ skin care line and the entire Elizabeth Arden skin care and color business. In addition, we anticipate sales from the recent acquisitions, a strong pipeline of new distributed brands in the U.S. mass retail market, the successful roll-out of recently launched brands and continued growth of our international business to contribute to the second half results.”
CONFERENCE CALL INFORMATION
The Company will host a conference call today at 10:00 a.m. Eastern Time. All interested parties can listen to a live web cast of the Company’s conference call by logging on to the Company’s web site at Company’s Calendar of Events. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Elizabeth Arden Corporate Website until March 31 2007.
Elizabeth Arden is a global prestige beauty products company. The Company’s portfolio of brands includes the Elizabeth Arden fragrance brands: Red Door, Elizabeth Arden 5th Avenue, Elizabeth Arden green tea and Elizabeth Arden Provocative Woman; the Elizabeth Taylor fragrance brands: White Diamonds and Elizabeth Taylor’s Passion; the fragrance brands of Britney Spears: curious Britney Spears and fantasy Britney Spears; the Hilary Duff fragrance With Love… Hilary Duff; the Danielle Steel fragrance Danielle by Danielle Steel; the classic fragrances: Design, Giorgio Beverly Hills, Halston and Halston Z-14, White Shoulders and Wings; the men’s fragrances: Daytona 500, GANT, Geoffrey Beene’s Grey Flannel, the HUMMER™ Fragrance for Men and PS Fine Cologne for Men; and the designer fragrance brands of Alfred Sung, Badgley Mischka and Bob Mackie; the Elizabeth Arden skin care lines, including Ceramide, Intervene and PREVAGE™ anti-aging treatment and the Elizabeth Arden color cosmetics line.
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance regarding net sales, earnings and cash flow from operations. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations:
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF OPERATIONS DATA (Unaudited) (In thousands, except percentages and per share data) Quarter Ended Six Months Ended ————————— ————————– December 31, December 31, December 31, December 31, 2006 2005 2006 2005 ———— ———— ———— ———— Net Sales $ 410,771 $ 345,893 $ 665,579 $ 573,271 Cost of Sales 252,817 200,133 408,399 338,445 ———— ———— ———— ———— Gross Profit 157,954 145,760 257,180 234,826 Gross Profit Percentage 38.5% 42.1% 38.6% 41.0% Selling, General and Administrative Expenses 108,322 86,105 195,606 162,495 Depreciation and Amortization 6,350 5,376 12,698 10,649 ———— ———— ———— ———— Total Operating Expenses 114,672 91,481 208,304 173,144 Interest Expense, Net 8,529 6,662 15,889 12,776 Income Before Income Taxes 34,753 47,617 32,987 48,906 Provision for Income Taxes 8,897 14,523 8,445 14,916 ———— ———— ———— ———— Net Income $ 25,856 $ 33,094 $ 24,542 $ 33,990 ============ ============ ============ ============ As reported: ————— Basic Income Per Share $ 0.94 $ 1.16 $ 0.89 $ 1.19 Diluted Income Per Share $ 0.91 $ 1.12 $ 0.86 1.15 Basic Shares 27,380 28,461 27,613 28,519 Diluted Shares 28,410 29,484 28,482 29,615 EBITDA (a) $ 49,632 $ 59,655 $ 61,574 $ 72,331 Adjusted to exclude the effect of restructuring charges, net of taxes (b): ————— Net Income $ 26,205 $ 33,094 $ 25,783 $ 33,990 Basic Income Per Share $ 0.96 $ 1.16 $ 0.93 $ 1.19 Diluted Income Per Share $ 0.92 $ 1.12 $ 0.91 $ 1.15 Basic Shares 27,380 28,461 27,613 28,519 Diluted Shares 28,410 29,484 28,482 29,615 EBITDA (a) $ 50,101 $ 59,655 $ 63,242 $ 72,331 (a) EBITDA is defined as net income plus the provision for income taxes, plus interest expense, plus depreciation and amortization. EBITDA should not be considered as an alternative to operating income or net income (as determined in accordance with generally accepted accounting principles (GAAP)) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with GAAP) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company’s operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure, depreciation and amortization or non-operating factors (such as historical cost). Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures. The following is a reconciliation of net income, as determined in accordance with GAAP, to EBITDA: (For a reconciliation of net income to EBITDA for prior periods, see the Company’s filings with the Securities and Exchange Commission which can be found on the Company’s website at www.elizabetharden.com). Three Months Ended Six Months Ended ————————- ————————- (In thousands) December 31, December 31, December 31, December 31, 2006 2005 2006 2005 ———— ———— ———— ———— Net income $ 25,856 $ 33,094 $ 24,542 $ 33,990 Plus: Provision for income taxes 8,897 14,523 8,445 14,916 Interest expense, net 8,529 6,662 15,889 12,776 Depreciation and amortization 6,350 5,376 12,698 10,649 ———— ———— ———— ———— EBITDA 49,632 59,655 61,574 72,331 Restructuring charges 469 – 1,668 – ———— ———— ———— ———— EBITDA excluding restructuring charges $ 50,101 $ 59,655 $ 63,242 $ 72,331 ============ ============ ============ ============ (1) The following table reconciles the calculation of net income per share on a basic and diluted basis from the amounts reported in accordance with GAAP to such amounts before giving effect to the impact of restructuring charges. This disclosure is being provided because we believe it is meaningful to our investors and other interested parties to understand the Company’s operating performance for comparability purposes and on a consistent basis without regard to the impact of restructuring charges. The presentation of the non- GAAP information titled ”Net income per share as adjusted, before the effect of the restructuring charges, net of taxes” is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with GAAP. (In thousands, except per share data) Three Months Ended Six Months Ended ————————- ————————- December 31, December 31, December 31, December 31, 2006 2005 2006 2005 ———— ———— ———— ———— As reported: —————— Basic Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 =========== =========== =========== =========== Weighted average shares outstanding as reported 27,380 28,461 27,613 28,519 =========== =========== =========== =========== Net income per basic share as reported $ 0.94 $ 1.16 $ 0.89 $ 1.19 =========== =========== =========== =========== Diluted Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 =========== =========== =========== =========== Weighted average shares and potential dilutive shares as reported 28,410 29,484 28,482 29,615 =========== =========== =========== =========== Net income per diluted share as reported $ 0.91 $ 1.12 $ 0.86 $ 1.15 =========== =========== =========== =========== Adjusted to exclude the effect of restructuring charges, net of taxes —————— Basic Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 Restructuring charges, net of tax 349 – 1,241 – ———– ———– ———– ———– Net income as adjusted, before the effect of the restructuring charges, net of taxes $ 26,205 $ 33,094 $ 25,783 $ 33,990 =========== =========== =========== =========== Weighted average shares outstanding as reported 27,380 28,461 27,613 28,519 =========== =========== =========== =========== Net income per share as adjusted, before the effect of the restructuring charges, net of taxes $ 0.96 $ 1.16 $ 0.93 $ 1.19 =========== =========== =========== =========== Diluted Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 Restructuring charges, net of tax 349 – 1,241 – ———– ———– ———– ———– Net income as adjusted, before the effect of the restructuring charges, net of taxes $ 26,205 $ 33,094 $ 25,783 $ 33,990 =========== =========== =========== =========== Weighted average shares outstanding as reported 28,410 29,484 28,482 29,615 =========== =========== =========== =========== Net income per diluted share as adjusted, before the effect of the restructuring charges, net of taxes $ 0.92 $ 1.12 $ 0.91 $ 1.15 =========== =========== =========== =========== CONSOLIDATED BALANCE SHEET DATA (Unaudited) (In thousands) December 31, June 30, December 31, 2006 2006 2005 ————- ————– ————- Cash $ 43,375 $ 28,466 $ 20,957 Accounts Receivable, Net 263,373 181,080 221,939 Inventories 308,811 269,270 227,261 Property and Equipment, Net 38,398 34,681 32,625 Exclusive Brand Licenses, Trademarks and Intangibles, Net 218,843 201,534 184,908 Total Assets 913,833 759,903 725,985 Short-Term Debt 114,600 40,000 20,474 Current Portion of Long- Term Debt 1,125 563 8,802 Current Liabilities 366,474 234,978 198,503 Long-Term Liabilities 247,890 247,078 234,351 Total Debt 340,670 265,951 254,276 Shareholders’ Equity 299,469 277,847 293,132 Working Capital 282,527 280,942 301,341
CONTACT: Elizabeth Arden, Inc.
Marcey Becker, 203-462-5809
or
Investor/Press:
Integrated Corporate Relations
Allison Malkin / Michael Fox, 203-682-8200
SOURCE: Elizabeth Arden, Inc.
NEW YORK — Feb. 1, 2007 — Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products company, today announced financial results for the fiscal 2007 second quarter ended December 31, 2006.
SECOND QUARTER RESULTS
Net sales increased 18.8% to $410.8 million for the three months ended December 31, 2006 from $345.9 million in the comparable period of the prior year. Sales growth was driven by a significant increase in fragrance brands sold to the Company’s mass retail customers, sales of new brands, including the With Love… Hilary Duff fragrance and the fragrance brands resulting from the June 2006 Riviera Concepts acquisition. In addition, higher sales of the Company’s Elizabeth Arden branded skin care and color products and growth in the Company’s businesses in China and Taiwan contributed to the net sales increase. Excluding the favorable impact of foreign currency translation, net sales increased 17.3%.
Net income for the three months ended December 31, 2006 was $26.2 million, or $0.92 per diluted share, excluding previously announced restructuring charges of $0.3 million after taxes related to the Company’s restructuring in its European operations, compared to net income of $33.1 million, or $1.12 per diluted share, in the same period last year. On a reported basis, net income was $25.9 million, or $0.91 per diluted share. As previously announced, the Company’s earnings for the second quarter of fiscal 2007 were impacted by transition and integration expenses associated with the Company’s recent acquisitions.
E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth Arden, Inc., commented, “We are pleased with our second quarter results and the general execution of our business. Our better than planned earnings reflect the strength of our broad-based business model, which spans multiple retail channels and geographies, as well as the strength of our brand portfolio. Overall, the recent acquisitions are performing ahead of our original expectations. We have completed the transition of the distribution activities out of the Sovereign Sales facility and are on schedule to integrate all remaining functions during the third fiscal quarter. Although With Love… Hilary Duff ranked among the top three Fall fragrance launches at U.S. department stores, our recently launched fragrances were short of our internal retail sales expectations, largely due to a softer than expected holiday season for fragrances at U.S. department stores. The rest of our business units, however, performed at or better than plan.”
Mr. Beattie continued, “Our U.S. mass retail business increased significantly, and we are expanding our market share. This growth was led by the acquisitions and the strength of the Britney Spears fragrance franchise, which experienced double-digit gains this quarter in sales to mass retailers as well as in our international markets.”
Mr. Beattie added, “In addition, net sales of our Elizabeth Arden branded skin care and color products rose 18% this quarter and 20% for the first half of the fiscal year. This is a result of our very strong product innovation and improved brand promotion and advertising globally. Our international business achieved another quarter of solid sales growth, with increases across most markets and particularly in Asia. Our focus on the Elizabeth Arden brand, including the introduction of products such as PREVAGE™ anti-aging treatment, is also resulting in improved retail sales and productivity at U.S. department stores. The repositioning of PREVAGE™ to the beauty counter, for example, has lifted the retail performance of our Elizabeth Arden skin care and color business.”
SIX MONTHS RESULTS
For the six-months ended December 31, 2006, net sales rose 16.1% to $665.6 million from $573.3 million for the six months ended December 31, 2005. Excluding the favorable impact of foreign currency translation, net sales increased 15.0%. Net income was $25.8 million, or $0.91 per diluted share, versus $34.0 million, or $1.15 million per diluted share, for the year-ago period. The results for the six months ended December 31, 2006 exclude restructuring charges of $1.2 million after taxes related to the Company’s previously announced restructuring charges. On a reported basis, net income was $24.5 million, or $0.86 per diluted share.
OUTLOOK
The Company confirms its fiscal 2007 annual net sales guidance. For the fiscal year, the Company currently anticipates net sales will increase by approximately 15% to 18%, assuming current foreign currency rates. The Company is raising the lower end of its fiscal 2007 earnings guidance range and currently estimates diluted earnings per share in the range of $1.15 to $1.20, versus its previous guidance range of $1.10 to $1.20.
The Company currently expects net sales to range between $215 million to $230 million for each of the third and fourth fiscal quarters. Diluted earnings per share for the third fiscal quarter are currently estimated to be in the range of $0.01 to $0.06. The Company expects to incur in its third fiscal quarter the final transition expenses for the Sovereign Sales acquisition and increased investment to support the global roll-out of the With Love… Hilary Duff fragrance, PREVAGE™ Eye skin treatment and the Intervene skin care line and the global launch of the new Elizabeth Arden fragrance, Elizabeth Arden Mediterranean.
Mr. Beattie concluded, “As we look forward to the second half of the year, we are excited about the global introduction of the new Elizabeth Arden fragrance, Elizabeth Arden Mediterranean, to support the strong growth of the Elizabeth Arden skin care and color business globally. Prevage Eye continues to gain traction and is lifting total sales of the Prevage™ skin care line and the entire Elizabeth Arden skin care and color business. In addition, we anticipate sales from the recent acquisitions, a strong pipeline of new distributed brands in the U.S. mass retail market, the successful roll-out of recently launched brands and continued growth of our international business to contribute to the second half results.”
CONFERENCE CALL INFORMATION
The Company will host a conference call today at 10:00 a.m. Eastern Time. All interested parties can listen to a live web cast of the Company’s conference call by logging on to the Company’s web site at Company’s Calendar of Events. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Elizabeth Arden Corporate Website until March 31 2007.
Elizabeth Arden is a global prestige beauty products company. The Company’s portfolio of brands includes the Elizabeth Arden fragrance brands: Red Door, Elizabeth Arden 5th Avenue, Elizabeth Arden green tea and Elizabeth Arden Provocative Woman; the Elizabeth Taylor fragrance brands: White Diamonds and Elizabeth Taylor’s Passion; the fragrance brands of Britney Spears: curious Britney Spears and fantasy Britney Spears; the Hilary Duff fragrance With Love… Hilary Duff; the Danielle Steel fragrance Danielle by Danielle Steel; the classic fragrances: Design, Giorgio Beverly Hills, Halston and Halston Z-14, White Shoulders and Wings; the men’s fragrances: Daytona 500, GANT, Geoffrey Beene’s Grey Flannel, the HUMMER™ Fragrance for Men and PS Fine Cologne for Men; and the designer fragrance brands of Alfred Sung, Badgley Mischka and Bob Mackie; the Elizabeth Arden skin care lines, including Ceramide, Intervene and PREVAGE™ anti-aging treatment and the Elizabeth Arden color cosmetics line.
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance regarding net sales, earnings and cash flow from operations. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations:
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF OPERATIONS DATA (Unaudited) (In thousands, except percentages and per share data) Quarter Ended Six Months Ended ————————— ————————– December 31, December 31, December 31, December 31, 2006 2005 2006 2005 ———— ———— ———— ———— Net Sales $ 410,771 $ 345,893 $ 665,579 $ 573,271 Cost of Sales 252,817 200,133 408,399 338,445 ———— ———— ———— ———— Gross Profit 157,954 145,760 257,180 234,826 Gross Profit Percentage 38.5% 42.1% 38.6% 41.0% Selling, General and Administrative Expenses 108,322 86,105 195,606 162,495 Depreciation and Amortization 6,350 5,376 12,698 10,649 ———— ———— ———— ———— Total Operating Expenses 114,672 91,481 208,304 173,144 Interest Expense, Net 8,529 6,662 15,889 12,776 Income Before Income Taxes 34,753 47,617 32,987 48,906 Provision for Income Taxes 8,897 14,523 8,445 14,916 ———— ———— ———— ———— Net Income $ 25,856 $ 33,094 $ 24,542 $ 33,990 ============ ============ ============ ============ As reported: ————— Basic Income Per Share $ 0.94 $ 1.16 $ 0.89 $ 1.19 Diluted Income Per Share $ 0.91 $ 1.12 $ 0.86 1.15 Basic Shares 27,380 28,461 27,613 28,519 Diluted Shares 28,410 29,484 28,482 29,615 EBITDA (a) $ 49,632 $ 59,655 $ 61,574 $ 72,331 Adjusted to exclude the effect of restructuring charges, net of taxes (b): ————— Net Income $ 26,205 $ 33,094 $ 25,783 $ 33,990 Basic Income Per Share $ 0.96 $ 1.16 $ 0.93 $ 1.19 Diluted Income Per Share $ 0.92 $ 1.12 $ 0.91 $ 1.15 Basic Shares 27,380 28,461 27,613 28,519 Diluted Shares 28,410 29,484 28,482 29,615 EBITDA (a) $ 50,101 $ 59,655 $ 63,242 $ 72,331 (a) EBITDA is defined as net income plus the provision for income taxes, plus interest expense, plus depreciation and amortization. EBITDA should not be considered as an alternative to operating income or net income (as determined in accordance with generally accepted accounting principles (GAAP)) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with GAAP) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company’s operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure, depreciation and amortization or non-operating factors (such as historical cost). Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures. The following is a reconciliation of net income, as determined in accordance with GAAP, to EBITDA: (For a reconciliation of net income to EBITDA for prior periods, see the Company’s filings with the Securities and Exchange Commission which can be found on the Company’s website at www.elizabetharden.com). Three Months Ended Six Months Ended ————————- ————————- (In thousands) December 31, December 31, December 31, December 31, 2006 2005 2006 2005 ———— ———— ———— ———— Net income $ 25,856 $ 33,094 $ 24,542 $ 33,990 Plus: Provision for income taxes 8,897 14,523 8,445 14,916 Interest expense, net 8,529 6,662 15,889 12,776 Depreciation and amortization 6,350 5,376 12,698 10,649 ———— ———— ———— ———— EBITDA 49,632 59,655 61,574 72,331 Restructuring charges 469 – 1,668 – ———— ———— ———— ———— EBITDA excluding restructuring charges $ 50,101 $ 59,655 $ 63,242 $ 72,331 ============ ============ ============ ============ (1) The following table reconciles the calculation of net income per share on a basic and diluted basis from the amounts reported in accordance with GAAP to such amounts before giving effect to the impact of restructuring charges. This disclosure is being provided because we believe it is meaningful to our investors and other interested parties to understand the Company’s operating performance for comparability purposes and on a consistent basis without regard to the impact of restructuring charges. The presentation of the non- GAAP information titled ”Net income per share as adjusted, before the effect of the restructuring charges, net of taxes” is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with GAAP. (In thousands, except per share data) Three Months Ended Six Months Ended ————————- ————————- December 31, December 31, December 31, December 31, 2006 2005 2006 2005 ———— ———— ———— ———— As reported: —————— Basic Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 =========== =========== =========== =========== Weighted average shares outstanding as reported 27,380 28,461 27,613 28,519 =========== =========== =========== =========== Net income per basic share as reported $ 0.94 $ 1.16 $ 0.89 $ 1.19 =========== =========== =========== =========== Diluted Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 =========== =========== =========== =========== Weighted average shares and potential dilutive shares as reported 28,410 29,484 28,482 29,615 =========== =========== =========== =========== Net income per diluted share as reported $ 0.91 $ 1.12 $ 0.86 $ 1.15 =========== =========== =========== =========== Adjusted to exclude the effect of restructuring charges, net of taxes —————— Basic Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 Restructuring charges, net of tax 349 – 1,241 – ———– ———– ———– ———– Net income as adjusted, before the effect of the restructuring charges, net of taxes $ 26,205 $ 33,094 $ 25,783 $ 33,990 =========== =========== =========== =========== Weighted average shares outstanding as reported 27,380 28,461 27,613 28,519 =========== =========== =========== =========== Net income per share as adjusted, before the effect of the restructuring charges, net of taxes $ 0.96 $ 1.16 $ 0.93 $ 1.19 =========== =========== =========== =========== Diluted Net income as reported $ 25,856 $ 33,094 $ 24,542 $ 33,990 Restructuring charges, net of tax 349 – 1,241 – ———– ———– ———– ———– Net income as adjusted, before the effect of the restructuring charges, net of taxes $ 26,205 $ 33,094 $ 25,783 $ 33,990 =========== =========== =========== =========== Weighted average shares outstanding as reported 28,410 29,484 28,482 29,615 =========== =========== =========== =========== Net income per diluted share as adjusted, before the effect of the restructuring charges, net of taxes $ 0.92 $ 1.12 $ 0.91 $ 1.15 =========== =========== =========== =========== CONSOLIDATED BALANCE SHEET DATA (Unaudited) (In thousands) December 31, June 30, December 31, 2006 2006 2005 ————- ————– ————- Cash $ 43,375 $ 28,466 $ 20,957 Accounts Receivable, Net 263,373 181,080 221,939 Inventories 308,811 269,270 227,261 Property and Equipment, Net 38,398 34,681 32,625 Exclusive Brand Licenses, Trademarks and Intangibles, Net 218,843 201,534 184,908 Total Assets 913,833 759,903 725,985 Short-Term Debt 114,600 40,000 20,474 Current Portion of Long- Term Debt 1,125 563 8,802 Current Liabilities 366,474 234,978 198,503 Long-Term Liabilities 247,890 247,078 234,351 Total Debt 340,670 265,951 254,276 Shareholders’ Equity 299,469 277,847 293,132 Working Capital 282,527 280,942 301,341
CONTACT: Elizabeth Arden, Inc.
Marcey Becker, 203-462-5809
or
Investor/Press:
Integrated Corporate Relations
Allison Malkin / Michael Fox, 203-682-8200
SOURCE: Elizabeth Arden, Inc.
I am disappointed with the new packaging on the Flawless Finish Loose Powder. The contents are the same weight but the packaging is much bigger in size and double the amount of plastic.
I am about to fly on a long distance holiday. Not all of your customers fly first class with limitless luggage allowed. Fortunately I am near the end of my current container, so will tip some from the new one into it for traveling. Also the cost of shipping worldwide by Arden must also have increased.
Unfortunately the new container is a disappointing non-descript colour. I much prefer the more sophisticated gold and black combination.
Is there anyway you can convey my concerns to the Parent Company? I have been an Elizabeth Arden customer for more years than would care to reveal and have had no cause to complain before.
Thank you for your consideration of the above.
All the best
Carol Parker
NEW YORK — (BUSINESS WIRE) — Aug. 17, 2006 — Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products company, today announced financial results for the fourth quarter and fiscal year ended June 30, 2006.
FISCAL 2006 RESULTS
In line with prior guidance, net sales increased 3.7% to $954.6 million for the fiscal year ended June 30, 2006 from $920.5 million for the fiscal year ended June 30, 2005. Excluding the unfavorable impact of foreign currency translation, net sales increased 4.4%.
Net income for the fiscal year ended June 30, 2006, was $34.2 million, or $1.15 per diluted share, excluding pre-tax charges of $0.8 million, or $0.02 per diluted share, associated with the early retirement of the remaining 11 3/4% Senior Notes and $1.2 million, or $0.03 per diluted share, associated with the previously announced organizational changes in the Company’s European operations. Adjusted for these charges and stock compensation expense related to FAS 123R, net income was $38.5 million or $1.29 per diluted share. This compares to $39.1 million or $1.30 per diluted share for the fiscal year ended June 30, 2005. The prior year results exclude the pre-tax impairment charge related to the sale of the Miami Lakes facility of $2.2 million, or $0.05 per diluted share. On a reported basis, net income for fiscal 2006 was $32.8 million, or $1.10 per diluted share.
Cash flow from operations was in-line with the Company’s expectations and increased over 80% to $65 million for fiscal 2006 from $35.5 million in fiscal 2005. In fiscal 2006, the Company also repurchased 1,338,127 shares of its common stock at an aggregate cost of $25.3 million, prepaid $9.3 million of long-term debt and completed the acquisition of the brand portfolio from Riviera Concepts Inc., a prestige fragrance company.
E. Scott Beattie, Chairman and Chief Executive Officer of Elizabeth Arden, Inc., commented, “While results were in line with our previous guidance, they were short of our original budget for fiscal 2006. Despite the strength of our new product introductions, external factors including the May Company and Federated Department Stores merger and resultant store closings, inventory reduction initiatives led by Wal-Mart, Target and other mass retailers and the general weakness experienced in the European markets in the first half of the fiscal year all had a negative impact on sales and operating margins this fiscal year. In addition, while the impact was incorporated into our original budget, the loss of distribution of certain brands related to the sale of the Unilever prestige fragrance brand portfolio resulted in a loss of mass retail volume this year as compared to last year. Fortunately, much of the impact from these factors is behind us and we expect improved revenue growth and operating performance from our business this year.”
The Company recently completed two acquisitions, including the acquisition of prestige fragrance distributor Sovereign Sales, LLC on August 11, 2006 and the acquisition of the brand licenses of Riviera Concepts Inc. in the fourth quarter of fiscal 2006. Sovereign Sales has been a distributor of prestige fragrances to mass retail customers in North America for over 20 years and distributes many top-ranked prestige fragrance brands to these retailers. The Company financed the acquisitions with a combination of free cash flow and borrowings under an expanded bank credit facility. The acquisitions are expected to be dilutive to earnings in the first half of fiscal 2007 due to integration-related costs, including redundant distribution, warehousing and other operating costs, increased investment to support the acquired brands and additional amortization and interest expense.
Mr. Beattie continued, “The recent acquisitions represent a great strategic fit for our Company, complementing our existing brand portfolio. The acquisitions will provide us with increased market share in the mass channel in North America and allow us to better leverage our sales and distribution infrastructure. In addition, the Riviera acquisition provides us with a number of exciting brands for specialty and prestige retailers globally. While transition costs related to the acquisitions will be dilutive to earnings in the first half of fiscal 2007, particularly in the first quarter, we expect the acquisitions to be accretive beginning in the second half of this fiscal year and into fiscal 2008. The revenue contribution from the acquisitions combined with the level of new product launches planned should position us to deliver double-digit increases in annual sales this year and to contribute strongly to our profitability and cash flow beginning in the second half of this fiscal year and in fiscal 2008.”
FOURTH QUARTER RESULTS
Net sales increased to $189.9 million for the three months ended June 30, 2006 from $187.1 million in the comparable three-month period of the prior fiscal year. The impact of foreign currency translation was not material.
Net loss per share improved to breakeven for the fourth quarter ended June 30, 2006 compared to a loss of $0.11 in the prior year period. Earnings results for the current year period exclude the FAS123R stock compensation expense and restructuring charges discussed above. Results for the comparable period of the prior year exclude the pre-tax impairment charge related to the sale of the Company’s Miami Lakes facility. Including the FAS 123R stock compensation expense, the loss for the fourth quarter of fiscal 2006 was $0.04 per share. On a reported basis, the Company had a loss of $0.07 per share for the fourth quarter of fiscal 2006 compared to a loss of $0.16 per share for same period of the prior fiscal year.
OUTLOOK
The Company currently anticipates annual net sales will increase by approximately 15% to 18% to $1.10 billion to $1.13 billion, assuming no impact from foreign currency translation. The net sales guidance is based on the successful introductions of the new fragrance launches and the expected contribution of the recent acquisitions. Certain external factors, including the impact to the Company’s travel retail business as a result of recent security measures implemented at airports, and the ability to integrate the acquisitions as planned may impact the Company’s guidance.
With respect to earnings guidance, acquisition-related costs, including transition expenses and higher interest and amortization costs are expected to impact earnings in fiscal 2007. In addition, the Company expects to incur increased advertising expenditures to support a significant level of launch activity, including the Hilary Duff, Danielle Steel and Badgley Mischka fragrances and the PREVAGE(TM) Eye anti-aging skin care product, all of which are launching in U.S department stores in the fall of 2006, and the new Mariah Carey and Elizabeth Arden fragrances scheduled to launch in the Spring of 2007. As a result of these activities, advertising and marketing expenses are expected to increase by approximately 20% in fiscal 2007 as compared to fiscal 2006. After considering these factors, the Company expects earnings for fiscal 2007 to be in the range of $1.10 to $1.20. The Company also expects cash flow from operations, excluding cash used for the purchase of Sovereign, to increase to approximately $100 million.
Regarding the first half of fiscal 2007, net sales are anticipated to increase by approximately 15% to 18% over the first half of fiscal 2006. Earnings per diluted share are expected to be below the first half of fiscal 2006, with the first quarter to be impacted more than the second quarter. The Company’s earnings for the first and second fiscal quarters are expected to reflect the acquisition-related costs and the timing of brand development and marketing expenditures to support the launches, which will be incurred primarily in the first fiscal quarter, and the leverage from increased sales volumes realized in the second fiscal quarter. Taking these factors into account, earnings per diluted share are expected to range between $0.75 and $0.85 for the six months ended December 31, 2006.
Mr. Beattie concluded, “This will be a busy year for us in terms of innovation as we are launching several new fragrance brands this year. Retailer reception for the fragrances from Hilary Duff and Danielle Steel is enthusiastic, with retailers expecting With Love… Hilary Duff to be a top three fragrance launch this fall season, and many retailers speculating it will be the number one launch and Danielle by Danielle Steel to surpass their original expectations after reviewing the brand and marketing campaign. In addition, the Badgley Mischka fragrance launched in July exclusively at Neiman Marcus and is off to a strong start. In the spring, we are launching a new fragrance under a license with Mariah Carey and a new Elizabeth Arden fragrance. PREVAGE(TM) remains a top three anti-aging product in its category, and we are launching an eye product this fall. Finally, our business in China and Taiwan is growing rapidly, with net sales more than doubling in the fourth quarter over the third quarter, and we will continue to invest in and develop these markets.”
CONFERENCE CALL INFORMATION
The Company will host a conference call today at 10:00 a.m. Eastern Time. All interested parties can listen to a live web cast of the Company’s conference call by logging on to the Company’s web site at http://phx.corporate-ir.net/phoenix.zhtml?c=98237&p=irol-calendar. An online archive of the broadcast will be available within one hour of the completion of the call and will be accessible on the Company’s web site at corporate.elizabetharden.com until September 17, 2006.
Elizabeth Arden is a global prestige beauty products company. The Company’s portfolio of brands includes the Elizabeth Arden fragrance brands: Red Door, Red Door Revealed, Elizabeth Arden 5th Avenue, Elizabeth Arden after five, Elizabeth Arden green tea, and Elizabeth Arden Provocative Woman; the Elizabeth Taylor fragrance brands: White Diamonds and Passion; the Britney Spears fragrance brands: curious Britney Spears, curious In Control and fantasy Britney Spears; the Hilary Duff fragrance With Love… Hilary Duff; the Danielle Steel fragrance Danielle by Danielle Steel; the men’s fragrances: Daytona 500, GANT adventure, the HUMMER(TM) Fragrance for Men and PS Fine Cologne for Men; and the designer fragrance brands of Alfred Sung, Badgley Mischka, Bob Mackie, Cynthia Rowley, Geoffrey Beene’s Grey Flannel, the Halston fragrance brands: Halston and Halston Z-14, Lulu Guinness and Nanette Lepore; the Elizabeth Arden skin care lines, including Ceramide and Eight Hour Cream, PREVAGE(TM) anti-aging treatment and the Elizabeth Arden color cosmetics line.
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Elizabeth Arden, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans” and “projection”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. Accordingly, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations: our absence of contracts with customers or suppliers and our ability to maintain and develop relationships with customers and suppliers; international and domestic economic and business changes that could impact consumer confidence and operations; the impact of competitive products and pricing; risks of international operations, including foreign currency fluctuations, economic and political consequences of terrorist attacks, political instability in certain regions of the world, and external factors affecting customer purchasing patterns; our ability to successfully launch new products and implement our growth strategy; our ability to successfully and cost-effectively integrate acquired businesses or new brands; our substantial indebtedness, debt service obligations and restrictive covenants in our revolving credit facility and our indenture for our 7 3/4% senior subordinated notes; our customers’ financial condition; our ability to access capital for acquisitions; changes in product mix to less profitable products; the retention and availability of key personnel; the assumptions underlying our critical accounting estimates; delays in shipments, inventory shortages and higher costs of production due to interruption of operations at key third party manufacturing or fulfillment facilities that manufacture or provide logistic services for the majority of our supply of certain products; changes in the retail, fragrance and cosmetic industries; our ability to protect our intellectual property rights; changes in the legal, regulatory and political environment that impact, or will impact, our business, including changes to customs or trade regulations or accounting standards; and other risks and uncertainties. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
ELIZABETH ARDEN, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF OPERATIONS DATA (Unaudited) (In thousands, except percentages and per share data) Three Months Ended Twelve Months Ended ___________________ ___________________ June 30, June 30, June 30, June 30, 2006 2005 2006 2005 _________ _________ _________ _________ Net Sales $189,935 $187,114 $954,550 $920,538 Cost of Sales 106,940 102,749 550,478 509,174 _________ _________ _________ _________ Gross Profit 82,995 84,365 404,072 411,364 Gross Profit Percentage (a) 43.7% 45.1% 42.3% 44.7% Selling, General and Administrative Expenses 75,281 77,361 313,706 309,170 Depreciation and Amortization 6,022 5,346 22,109 21,505 _________ _________ _________ _________ Total Operating Expenses 81,303 82,707 335,815 330,675 Interest Expense, Net 5,304 5,685 23,424 23,526 Impairment Charge on Miami Lakes Facility __ 2,156 __ 2,156 Debt Extinguishment Charges __ __ 758 __ _________ _________ _________ _________ (Loss) Income Before Income Taxes (3,612) (6,183) 44,075 55,007 (Benefit from) Provision for Income Taxes (1,714) (1,660) 11,281 17,403 _________ _________ _________ _________ Net (Loss) Income $ (1,898) $ (4,523) $ 32,794 $ 37,604 ========= ========= ========= ========= As reported: ____________ Basic (Loss) Income Per Share $ (0.07) $ (0.16) $ 1.15 $ 1.35 Diluted (Loss) Income Per Share $ (0.07) $ (0.16) $ 1.10 $ 1.25 Basic Shares 28,405 28,434 28,628 27,792 Diluted Shares 28,405 28,434 29,818 30,025 EBITDA (b) $ 7,714 $ 4,848 $ 89,608 $100,038 Adjusted before giving effect to the adoption of FAS 123R, share-based payments, debt extinguishment charge and other charges (c) Net Income (Loss) $ 103 $ (3,055) $ 38,510 $ 39,072 Basic Income Per Share $ 0.00 $ (0.11) $ 1.35 $ 1.41 Diluted Income Per Share $ 0.00 $ (0.11) $ 1.29 $ 1.30 Basic Shares 28,405 28,434 28,628 27,792 Diluted Shares 28,405 28,434 29,818 30,025 EBITDA (b) $ 10,404 $ 7,004 $ 97,291 $102,194 (a) Based on the percentage of net sales for the periods. (b) EBITDA is defined as net income plus the provision for income taxes (or net loss less the benefit from income taxes), plus interest expense, plus depreciation and amortization. EBITDA should not be considered as an alternative to operating income (loss) or net income (loss) (as determined in accordance with generally accepted accounting principles (GAAP)) as a measure of our operating performance or to net cash provided by operating, investing and financing activities (as determined in accordance with GAAP) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company’s operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure, depreciation and amortization or non-operating factors (such as historical cost). Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures. The following is a reconciliation of net income (loss), as determined in accordance with GAAP, to EBITDA: (For a reconciliation of net income to EBITDA for prior periods, see the Company’s filings with the Securities and Exchange Commission which can be found on the Company’s website at corporate.elizabetharden.com). Three Months Twelve Months Ended Ended _________________ __________________ June 30, June 30, June 30, June 30, 2006 2005 2006 2005 ________ ________ ________ _________ Net (loss) income $(1,898) $(4,523) $32,794 $ 37,604 Plus: (Benefit from) provision for income taxes (1,714) (1,660) 11,281 17,403 Interest expense, net 5,304 5,685 23,424 23,526 Depreciation and amortization 6,022 5,346 22,109 21,505 ________ ________ ________ _________ EBITDA 7,714 4,848 89,608 100,038 Debt extinguishment charges __ __ 758 __ FAS 123R - Share-based awards 1,517 __ 5,752 __ Restructuring charges 1,173 __ 1,173 __ Impairment charge on sale of Miami Lakes facility __ 2,156 __ 2,156 ________ ________ ________ _________ EBITDA excluding charges $10,404 $ 7,004 $97,291 $102,194 ======== ======== ======== ========= (c) The following tables reconcile the calculation of net income per share on a basic and fully diluted basis from the amounts reported in accordance with GAAP to such amounts before giving effect to the impact of adopting FAS 123R, share-based payments, net of taxes, debt extinguishment charge and other charges. This disclosure is being provided because we believe it is meaningful to our investors and other interested parties to understand the Company’s operating performance for comparability purposes and on a consistent basis without regard to the impact of adopting FAS 123R, share-based payments, debt extinguishment charge and other charges. The presentation of the non-GAAP information titled “Net income per share as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, debt extinguishment charge and other charges, net of taxes” or “Net income per diluted share as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, debt extinguishment charge and other charges, net of taxes” is not meant to be considered in isolation or as a substitute for net income or diluted income per share prepared in accordance with GAAP. (In thousands, except per share Three Months Twelve Months data) Ended Ended _________________ _________________ June 30, June 30, June 30, June 30, 2006 2005 2006 2005 ________ ________ ________ ________ As reported: ____________ Basic Net income as reported $(1,898) $(4,523) $32,794 $37,604 ======== ======== ======== ======== Weighted average shares outstanding as reported 28,405 28,434 28,628 27,792 ======== ======== ======== ======== Net income per basic share as reported $ (0.07) $ (0.16) $ 1.15 $ 1.35 ======== ======== ======== ======== Diluted Net income as reported $(1,898) $(4,523) $32,794 $37,604 ======== ======== ======== ======== Weighted average shares and potential dilutive shares as reported 28,405 28,434 29,818 30,025 ======== ======== ======== ======== Net income per diluted share as reported $ (0.07) $ (0.16) $ 1.10 $ 1.25 ======== ======== ======== ======== Adjusted before giving effect to the adoption of FAS 123R, share-based payments, debt extinguishment charge and other charges, net of taxes __________________________________ Basic Net (loss) income as reported $(1,898) $(4,523) $32,794 $37,604 Debt extinguishment charge, net of taxes __ __ 564 __ Restructuring charges, net of taxes 872 __ 872 __ Impairment charge- sale of Miami Lakes Facility, net of taxes __ 1,468 __ 1,468 ________ ________ ________ ________ Net (loss) income as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, net of taxes (1,026) (3,055) 34,230 39,072 Impact of adopting FAS 123R, share-based payments, net of taxes 1,129 __ 4,280 __ ________ ________ ________ ________ Net income (loss) as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, debt extinguishment charge and other charges, net of taxes $ 103 $(3,055) $38,510 $39,072 ======== ======== ======== ======== Weighted average shares outstanding as reported 28,405 28,434 28,628 27,792 ======== ======== ======== ======== Net (loss) income per share as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, net of taxes $ (0.04) $ (0.11) $ 1.20 $ 1.41 ======== ======== ======== ======== Net income (loss) per share as adjusted, before giving effect to the adoption of FAS 123R, share-based payments debt extinguishment charge and other charges, net of taxes $ 0.00 $ (0.11) $ 1.35 $ 1.41 ======== ======== ======== ======== (In thousands, except per share Three Months Twelve Months data) Ended Ended _________________ _________________ June 30, June 30, June 30, June 30, 2006 2005 2006 2005 ________ ________ ________ ________ Diluted Net (loss) income as reported $(1,898) $(4,523) $32,794 $37,604 Debt extinguishment charge, net of taxes __ __ 564 __ Restructuring charges, net of taxes 872 __ 872 __ Impairment charge- sale of Miami Lakes Facility, net of taxes __ 1,468 __ 1,468 ________ ________ ________ ________ Net (loss) income as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, net of taxes (1,026) (3,055) 34,230 39,072 Impact of adopting FAS 123R, share-based payments and debt extinguishment charge, net of taxes 1,129 __ 4,280 __ ________ ________ ________ ________ Net income (loss) as adjusted, before giving effect to the adoption of FAS 123R, share-based payments, debt exting